Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition ; volume:24 ; number:1 ; day:19 ; month:6 ; year:2023 ; pages:1-8 ; date:12.2023
BMC nephrology ; 24, Heft 1 (19.6.2023), 1-8, 12.2023
- Creator
-
Catanese, Lorenzo
Link, Katharina
Rupprecht, Harald
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-023-03228-9
- URN
-
urn:nbn:de:101:1-2023092208391495282501
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Catanese, Lorenzo
- Link, Katharina
- Rupprecht, Harald
- SpringerLink (Online service)
Other Objects (12)
Complement, thrombotic microangiopathy and disseminated intravascular coagulation
Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
Nintedanib-Induced Renal Thrombotic Microangiopathy
Complement C5a blockade is sufficient to resolve crystalline thrombotic microangiopathy
Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report
New-Onset Complement-Mediated Thrombotic Microangiopathy during the COVID-19 Pandemic
Differential diagnosis of thrombotic microangiopathy in nephrology
Narsoplimab for severe transplant-associated thrombotic microangiopathy
Thrombotic microangiopathy following haematopoietic stem cell transplant
Oxaliplatin-induced thrombotic microangiopathy: a case report
Thrombotic microangiopathy associated with Valproic acid toxicity
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy
Complement, thrombotic microangiopathy and disseminated intravascular coagulation
Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
Nintedanib-Induced Renal Thrombotic Microangiopathy
Complement C5a blockade is sufficient to resolve crystalline thrombotic microangiopathy
Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report
New-Onset Complement-Mediated Thrombotic Microangiopathy during the COVID-19 Pandemic
Differential diagnosis of thrombotic microangiopathy in nephrology
Narsoplimab for severe transplant-associated thrombotic microangiopathy
Thrombotic microangiopathy following haematopoietic stem cell transplant
Oxaliplatin-induced thrombotic microangiopathy: a case report
Thrombotic microangiopathy associated with Valproic acid toxicity
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy
Complement, thrombotic microangiopathy and disseminated intravascular coagulation
Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
Nintedanib-Induced Renal Thrombotic Microangiopathy
Complement C5a blockade is sufficient to resolve crystalline thrombotic microangiopathy
Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report
New-Onset Complement-Mediated Thrombotic Microangiopathy during the COVID-19 Pandemic
Differential diagnosis of thrombotic microangiopathy in nephrology
Narsoplimab for severe transplant-associated thrombotic microangiopathy
Thrombotic microangiopathy following haematopoietic stem cell transplant
Oxaliplatin-induced thrombotic microangiopathy: a case report
Thrombotic microangiopathy associated with Valproic acid toxicity